184. WITHDRAWN: Treatment Effect of Combination of Nsaid and Antitussives in Patients With URTI-Related Cough.
作者: Federico Saibene.;Alessandro Zanasi.;Luigi Lanata.;Rossella Sorbo.;Francesco de Blasio.
来源: Chest. 2016年150卷4S期151A页
The Publisher regrets that this article is an accidental duplication of an article that has already been published in Eur Respir J. 46 (2015) PA3852, http://dx.doi.org/10.1183/13993003.congress-2015.PA3852. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
185. Association of Sarcoidosis With Increased Risk of VTE: A Population-Based Study, 1976 to 2013.
The goal of this study was to investigate the risk of VTE among patients with sarcoidosis.
186. Hospital Volume and Outcomes of Robot-Assisted Lobectomies.
作者: Lise N Tchouta.;Henry S Park.;Daniel J Boffa.;Justin D Blasberg.;Frank C Detterbeck.;Anthony W Kim.
来源: Chest. 2017年151卷2期329-339页
The positive impact of hospital operative volume on outcomes following video-assisted thoracoscopic surgery has been established. The goal of this study was to determine whether or not this volume/outcome relationship translates to robot-assisted thoracoscopic surgery (RobATS) lobectomy.
187. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
作者: Sanjay Mehta.;Bhagavatula Kutumba Srinivasa Sastry.;Rogério Souza.;Adam Torbicki.;Hossein-Ardeschir Ghofrani.;Richard N Channick.;Marion Delcroix.;Tomás Pulido.;Gérald Simonneau.;John Wlodarczyk.;Lewis J Rubin.;Pavel Jansa.;Elke Hunsche.;Nazzareno Galiè.;Loïc Perchenet.;Olivier Sitbon.
来源: Chest. 2017年151卷1期106-118页
Pulmonary arterial hypertension (PAH) leads to reduced health-related quality of life (HRQoL). The objectives of this analysis were to evaluate the effect of macitentan on HRQoL in patients with PAH in the Study with an Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome (SERAPHIN) study. The association between baseline HRQoL and long-term outcomes was also investigated.
188. Clinical Predictors of Hospital Mortality Differ Between Direct and Indirect ARDS.
作者: Liang Luo.;Ciara M Shaver.;Zhiguo Zhao.;Tatsuki Koyama.;Carolyn S Calfee.;Julie A Bastarache.;Lorraine B Ware.
来源: Chest. 2017年151卷4期755-763页
Direct (pulmonary) and indirect (extrapulmonary) ARDS are distinct syndromes with important pathophysiologic differences. The goal of this study was to determine whether clinical characteristics and predictors of mortality differ between direct or indirect ARDS.
189. Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Retrospective Analysis of 74 Cases.
作者: Kamonpun Ussavarungsi.;Ryan M Kern.;Anja C Roden.;Jay H Ryu.;Eric S Edell.
来源: Chest. 2017年151卷2期400-408页
Diagnostic evaluation of patients with diffuse parenchymal lung disease (DPLD) is best achieved by a multidisciplinary team correlating clinical, radiological, and pathologic features. Surgical lung biopsy remains the gold standard for histopathologic diagnosis of idiopathic interstitial pneumonias. Emerging data suggest an increasing role for transbronchial cryobiopsy (TBC) in DPLD evaluation. We describe our experience with TBC in patients with DPLD.
190. Comparing Quality of Dying and Death Perceived by Family Members and Nurses for Patients Dying in US and Dutch ICUs.
作者: Rik T Gerritsen.;Matty Koopmans.;José G M Hofhuis.;J Randall Curtis.;Hanne Irene Jensen.;Jan G Zijlstra.;Ruth A Engelberg.;Peter E Spronk.
来源: Chest. 2017年151卷2期298-307页
The Quality of Dying and Death (QODD) questionnaire is used as a self-reported measure to allow families and clinicians to assess patients' quality of dying and death. We evaluated end-of-life (EOL) experiences as measured by the QODD completed by families and nurses in the United States and the Netherlands to explore similarities and differences in these experiences and identify opportunities for improving EOL care.
191. Effectiveness of a Critical Care Ultrasonography Course.
作者: Yonatan Y Greenstein.;Ross Littauer.;Mangala Narasimhan.;Paul H Mayo.;Seth J Koenig.
来源: Chest. 2017年151卷1期34-40页
Widespread use of critical care ultrasonography (CCUS) for the management of patients in the ICU requires an effective training program. The effectiveness of national and regional CCUS training courses is not known. This study describes a national-level, simulation-based, 3-day CCUS training program and evaluates its effectiveness.
192. Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine.
作者: Kimberly J Dunham-Snary.;Danchen Wu.;Edward A Sykes.;Amar Thakrar.;Leah R G Parlow.;Jeffrey D Mewburn.;Joel L Parlow.;Stephen L Archer.
来源: Chest. 2017年151卷1期181-192页
Hypoxic pulmonary vasoconstriction (HPV) is a homeostatic mechanism that is intrinsic to the pulmonary vasculature. Intrapulmonary arteries constrict in response to alveolar hypoxia, diverting blood to better-oxygenated lung segments, thereby optimizing ventilation/perfusion matching and systemic oxygen delivery. In response to alveolar hypoxia, a mitochondrial sensor dynamically changes reactive oxygen species and redox couples in pulmonary artery smooth muscle cells (PASMC). This inhibits potassium channels, depolarizes PASMC, activates voltage-gated calcium channels, and increases cytosolic calcium, causing vasoconstriction. Sustained hypoxia activates rho kinase, reinforcing vasoconstriction, and hypoxia-inducible factor (HIF)-1α, leading to adverse pulmonary vascular remodeling and pulmonary hypertension (PH). In the nonventilated fetal lung, HPV diverts blood to the systemic vasculature. After birth, HPV commonly occurs as a localized homeostatic response to focal pneumonia or atelectasis, which optimizes systemic Po2 without altering pulmonary artery pressure (PAP). In single-lung anesthesia, HPV reduces blood flow to the nonventilated lung, thereby facilitating thoracic surgery. At altitude, global hypoxia causes diffuse HPV, increases PAP, and initiates PH. Exaggerated or heterogeneous HPV contributes to high-altitude pulmonary edema. Conversely, impaired HPV, whether due to disease (eg, COPD, sepsis) or vasodilator drugs, promotes systemic hypoxemia. Genetic and epigenetic abnormalities of this oxygen-sensing pathway can trigger normoxic activation of HIF-1α and can promote abnormal metabolism and cell proliferation. The resulting pseudohypoxic state underlies the Warburg metabolic shift and contributes to the neoplasia-like phenotype of PH. HPV and oxygen sensing are important in human health and disease.
193. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.
作者: Bethany T Samuelson.;Adam Cuker.;Deborah M Siegal.;Mark Crowther.;David A Garcia.
来源: Chest. 2017年151卷1期127-138页
Direct oral anticoagulants (DOACs) are the treatment of choice for most patients with atrial fibrillation and/or noncancer-associated venous thromboembolic disease. Although routine monitoring of these agents is not required, assessment of anticoagulant effect may be desirable in special situations. The objective of this review was to summarize systematically evidence regarding laboratory assessment of the anticoagulant effects of dabigatran, rivaroxaban, apixaban, and edoxaban.
194. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes.
作者: Shipra Gupta.;Ankit Sakhuja.;Gagan Kumar.;Eric McGrath.;Rahul S Nanchal.;Kianoush B Kashani.
来源: Chest. 2016年150卷6期1251-1259页
Although 28% to 49% of severe sepsis hospitalizations have been described as being "culture negative," there are very limited data on the epidemiology and outcomes of those with culture-negative severe sepsis (CNSS). The objectives of this study were to investigate the proportion and trends of CNSS and its association with mortality.
195. Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
作者: Snigdha Jain.;Rohan Khera.;Saket Girotra.;David Badesch.;Zhen Wang.;Mohammad Hassan Murad.;Amy Blevins.;Gregory A Schmidt.;Siddharth Singh.;Alicia K Gerke.
来源: Chest. 2017年151卷1期90-105页
We conducted a systematic review and network meta-analysis to examine comparative efficacy and tolerability of pharmacologic interventions for pulmonary arterial hypertension (PAH).
196. Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report.
作者: Peter J Kahrilas.;Kenneth W Altman.;Anne B Chang.;Stephen K Field.;Susan M Harding.;Andrew P Lane.;Kaiser Lim.;Lorcan McGarvey.;Jaclyn Smith.;Richard S Irwin.; .
来源: Chest. 2016年150卷6期1341-1360页
We updated the 2006 ACCP clinical practice guidelines for management of reflux-cough syndrome.
197. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival.
作者: Ying Zhou.;Elyse E Lower.;Hui-Ping Li.;Alexandru Costea.;Mehran Attari.;Robert P Baughman.
来源: Chest. 2017年151卷1期139-148页
To assess the clinical characteristics, diagnosis, and outcome of cardiac sarcoidosis in a single institution sarcoidosis clinic.
198. A 34-Year-Old Pregnant Woman With Cough, Chest Pain, and a Left Upper Lobe Mass.
作者: Sujith V Cherian.;Karunakar Akasapu.;Anupam Kumar.;Shakuntala H Mauzo.;Meenakshi B Bhattacharjee.
来源: Chest. 2016年150卷3期e87-91页
A 34-year-old white woman who was 30 weeks' pregnant initially presented to her primary care physician with a cough for which she was given antibiotics, but she had persistent symptoms. These were followed by chest pain, as a result of which she was referred to our department. She had a past medical history of hypertension, and currently was in her sixth pregnancy, with no reported complications in the previous pregnancies. Review of systems was otherwise negative. She had a three-pack-year smoking history, but denied smoking during her current pregnancy.
199. Ten Years of Chronic Cough in a 64-Year-Old Man With Multiple Pulmonary Nodules.
作者: Whittney A Warren.;Scott S Dalane.;Bryce D Warren.;Paul G Peterson.;Rodney D Boyum.;William Kelly.
来源: Chest. 2016年150卷3期e81-5页
A 64-year-old male former smoker with a history of prostate cancer presented to our pulmonary clinic, complaining of nonproductive cough for 10 years. Prior evaluation included treatment for upper airway cough syndrome and gastroesophageal reflux, stopping angiotensin-converting enzyme inhibitor, and initiation of inhaled β-agonists. Esophageal pH monitoring indicated silent reflux, and proton pump inhibitor therapy was started. He continued to cough and complain of dyspnea. Physical examination produced unremarkable results, with no evidence of lymphadenopathy. Pulmonary function tests showed a pseudo-restrictive pattern with air trapping, hyperreactivity, and incomplete bronchodilator responsiveness: FEV1, 2.48 L (69% of predicted); FVC, 3.57 L (75% of predicted); FEV1/FVC, 92%; total lung capacity, 7.00 L (100% of predicted); and residual volume, 3.05 L (136% of predicted). Laboratory studies, including a complete metabolic panel, prostate-specific antigen test, and complete blood count, yielded normal results.
|